Voglio sapere a riguardo di…

7989

Notices
Federal Register Vol. 86, No. 21
Wednesday, February 3, 2021

This section of the FEDERAL REGISTER
contains documents other than rules or proposed rules that are applicable to the public. Notices of hearings and investigations, committee meetings, agency decisions and rulings, delegations of authority, filing of petitions and applications and agency statements of organization and functions are examples of documents appearing in this section.

DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board B042021

jbell on DSKJLSW7X2PROD with NOTICES

Foreign-Trade Zone FTZ 22
Chicago, Illinois, Notification of Proposed Production Activity, AbbVie, Inc. Pharmaceutical Products, North Chicago and Lake County, Illinois AbbVie, Inc. AbbVie submitted a notification of proposed production activity to the FTZ Board for its facilities in North Chicago and Lake County, Illinois. The notification conforming to the requirements of the regulations of the FTZ Board 15 CFR
400.22 was received on January 27, 2021.
AbbVie already has authority to produce pharmaceutical products within Subzone 22S. The current request would add a finished product and a foreign status material to the scope of authority. Pursuant to 15 CFR
400.14b, additional FTZ authority would be limited to the specific foreignstatus material and specific finished product described in the submitted notification as described below and subsequently authorized by the FTZ
Board.
Production under FTZ procedures could exempt AbbVie from customs duty payments on the foreign-status materials/components used in export production. On its domestic sales, for the foreign-status materials/components noted below and in the existing scope of authority, AbbVie would be able to choose the duty rates during customs entry procedures that applies to IMBRUVICA tablets duty-free.
AbbVie would be able to avoid duty on foreign-status components which become scrap/waste. Customs duties also could possibly be deferred or reduced on foreign-status production equipment.
The material sourced from abroad is Ibrutinib active pharmaceutical
VerDate Sep<11>2014

17:21 Feb 02, 2021

Jkt 253001

ingredient duty rate 6.5%. The request indicates that Ibrutinib is subject to duties under Section 301 of the Trade Act of 1974 Section 301, depending on the country of origin. The applicable Section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status 19 CFR
146.41.
Public comment is invited from interested parties. Submissions shall be addressed to the Boards Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is March 15, 2021.
A copy of the notification will be available for public inspection in the Reading Room section of the Boards website, which is accessible via www.trade.gov/ftz.
For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov.
Dated: January 28, 2021.
Andrew McGilvray, Executive Secretary.
FR Doc. 202102234 Filed 2221; 8:45 am BILLING CODE 3510DSP

DEPARTMENT OF COMMERCE
International Trade Administration A549833

Citric Acid and Certain Citrate Salts From Thailand: Partial Rescission of Antidumping Duty Administrative Review, 20192020
Enforcement and Compliance, International Trade Administration, Department of Commerce.
SUMMARY: The Department of Commerce Commerce is rescinding the administrative review of the antidumping duty order on citric acid and certain citrate salts citric acid from Thailand covering the period of review POR July 1, 2019, through June 30, 2020, in part, with respect to Niran Thailand Co., Ltd. Niran, based on a timely withdrawal of the request for review for Niran.
DATES: Applicable February 3, 2021.
FOR FURTHER INFORMATION CONTACT: Joy Zhang, AD/CVD Operations, Office III, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington, DC 20230; telephone: 202 4821168.
AGENCY:

PO 00000

Frm 00001

Fmt 4703

Sfmt 4703

SUPPLEMENTARY INFORMATION:

Background On July 1, 2020, Commerce published in the Federal Register a notice of opportunity to request an administrative review of the antidumping duty order on citric acid from Thailand for the period July 1, 2019, through June 30, 2020.1 Based on timely requests from COFCO Biochemical Thailand Co., Ltd. COFCO, Sunshine Biotech International Co., Ltd. Sunshine, and Archer Daniels Midland Company, Cargill, Incorporated, and Tate & Lyle Ingredients Americas LLC, domestic producers of the subject merchandise and petitioners in the original investigation collectively, the petitioners,2 on September 3, 2020, in accordance with 751a1 of the Tariff Act of 1930, as amended the Act, Commerce published in the Federal Register a notice of initiation of administrative review covering COFCO, Sunshine, and Niran.3 On September 17, 2020, Commerce selected COFCO
and Sunshine for individual examination and issued the antidumping duty questionnaire to the companies.4
On September 18, 2020, Niran filed a no-shipment certification.5 On October 8, 2020, U.S. Customs and Border Protection CBP confirmed that there were no shipments of subject merchandise from Niran during the 1 See Antidumping or Countervailing Duty Order, Finding, or Suspended Investigation; Opportunity to Request Administrative Review, 85 FR 39531
July 1, 2020.
2 See COFCOs Letter, Citric Acid and Certain Citrate Salts from Thailand: Request for Administrative Review, dated July 28, 2020; see also Sunshines Letter, Antidumping Duty Investigation of Citric Acid and Certain Citrate Salts from Thailand: Sunshine Biotech Request for Review, dated July 31, 2020; and Petitioners Letter, Citric Acid and Certain Citrate Salts From Thailand: Petitioners Request For Administrative Review, dated July 30, 2020 the petitioners requested review of COFCO, Sunshine, and Niran.
3 See Initiation of Antidumping and Countervailing Duty Administrative Reviews, 85 FR
172 September 3, 2020.
4 See Memorandum, Antidumping Duty Administrative Review of Citric Acid and Certain Citrate Salts from Thailand; 20192020: Selection of Respondents for Individual Examination, dated September 17, 2020. See also Antidumping Questionnaires sent to COFCO and Sunshine, dated September 21, 2020.
5 See Nirans Letter, Citric Acid and Certain Citrate Salts from Thailand: No Shipment Certification, dated September 18, 2020.

E:FRFM03FEN1.SGM

03FEN1